Home LiteratureArticle Details
PMID: 6426985 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Sexual agglutinin of mating-type minus gametes in Chlamydomonas reinhardii. I. Loss and recovery of agglutinability of gametes treated with EDTA.

Experimental cell research ·Vol. 152 ·No. 2 ·1984-06-00 ·Pages 322-30

Saito T, Matsuda Y

Abstract

The effect of EDTA on the mating-type-specific agglutinins located on the flagellar surfaces of Chlamydomonas reinhardii gametes was investigated. The mating-type minus (mt-) gametes lost their agglutinability without apparent loss of motility soon after addition of EDTA at low concentrations (1-2 mM). At the same time, the cells released into the medium agglutinins which can elicit agglutinative responses of mating-type plus (mt+) gametes specifically. When EDTA was neutralized with Mg2+ or removed by centrifugation, the mt- cells quickly replaced agglutinins by protein synthesis: the recovery process was sensitive to cycloheximide, but not to tunicamycin. The EDTA-treated mt+ gametes lost their agglutinins much more slowly than the mt- gametes. The replacement of mt+ agglutinins was inhibited by both cycloheximide and tunicamycin.

MeSH Terms
Agglutination/drug effects Chlamydomonas Cycloheximide/pharmacology Edetic Acid/pharmacology Germ Cells Kinetics Lectins/isolation & purification Magnesium/pharmacology
Chemicals
Lectins Cycloheximide Edetic Acid Magnesium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Saito T
Matsuda Y
Article Info
Journal
Experimental cell research
Abbr.
Exp Cell Res
ISSN
0014-4827
Published
1984-06-00
Pages
322-30
Language
English
Region
United States
NLM ID
0373226
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com